FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.
If you need to generate income from your investments, selecting securities or funds based on their current interest or ...
The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...
Nathan Eigerman: The Value Line® Index* represents a higher dividend yield core U.S. equity portfolio. Some investors are ...
Worried about the next round of tariffs? Tech disruption from DeepSeek? The geopolitical landscape? Then these low-beta ...
Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.
We recently published a list of 10 Best Dividend Stocks Yielding at Least 7% According to Analysts. In this article, we are ...